Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1

Kidney Int. 2023 May;103(5):990-993. doi: 10.1016/j.kint.2023.01.029. Epub 2023 Mar 4.
No abstract available

Keywords: hyperoxaluria; lumasiran; pediatric nephrology; stable isotopes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alcohol Oxidoreductases
  • Humans
  • Hyperoxaluria*
  • Hyperoxaluria, Primary* / diagnosis
  • Hyperoxaluria, Primary* / drug therapy
  • Hyperoxaluria, Primary* / genetics
  • Oxalates

Substances

  • glycollate oxidase
  • lumasiran
  • Alcohol Oxidoreductases
  • Oxalates

Supplementary concepts

  • Primary hyperoxaluria type 1